Alvotech And Bioventure Celebrate Egyptian Adalimumab Nod

Partnered AVT02 Biosimilar Rival To Humira Approved As Adalimumab-EVA

 
• By David Wallace
  
Syringe and vial labelled with Egyptian flag
Alvotech and Bioventure have celebrated an Egyptian biosimilar approval • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products